News | April 20, 2011

GE Healthcare Acquires Assets of Steady State MRI

April 20, 2011 – GE Healthcare has acquired the assets of Steady State Imaging (SSI), a Minneapolis-based company that develops magnetic resonance imaging (MRI) technology. The terms of agreement were not disclosed.

Through this acquisition, GE Healthcare’s magnetic resonance imaging business expands its current advanced technology portfolio with the addition of the University of Minnesota’s SWIFT method, which allows the visualization of tendons, ligaments and other tissues not normally seen using conventional imaging methods. The SWIFT method has gained interest among MRI researchers for its potential for imaging in areas near the lungs and other parts of the body where conventional MRI is not typically effective.

"The acquisition of SSI is very much aligned with GE's healthymagination initiative to measurably reduce cost, improve quality and increase access to technology for more people," said Jim Davis, vice president and general manager of GE Healthcare's global MR business. "We are excited at the prospect of implementing SSI's technology and continue to invest in innovations that will have an impact on our customers and their patients.”

“We are delighted that our technology is now in the very capable hands of GE, a company with significant technical and marketing capabilities,” said SSI CEO, Danny Cunagin. “Our shareholders unanimously approved the sale and are very excited. We look forward to learning how our technology will be commercialized by GE in the future.”

“The fact that a startup company based on University of Minnesota technology is being acquired by an industry leader like GE Healthcare is tremendous news,” said Tim Mulcahy, vice president for research at the University of Minnesota. “This not only helps fulfill our mission of moving researcher inventions to the public domain as quickly as possible, it also validates the innovative work of Dr. Garwood and his co-inventors at the University’s Center for Magnetic Resonance Research.”

For more information: www.gehealthcare.com

Related Content

Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...